Optimal management of transmural myocardial infarction (MI) depends on rapid reperfusion of the occluded infarct artery.
Diabetics are known to have higher rates of restenosis after revascularization than non-diabetic subjects.
The ACC/AHA guidelines recommend perioperative beta blockers for those already on them, patients undergoing vascular surgery, or those having intermediate- to high-risk surgery with established coronary heart disease, or at high risk of having it.
Percutaneous intervention for peripheral arterial disease (PAD) results in improvement in claudication symptoms but is complicated by a high rate of restenosis.
Imagine a new disease strikes your community that significantly increases mortality rates, particularly in critically ill patients. This same disease causes patients to suffer more pain, greater heart damage from a myocardial infarction, and, if they are elderly, increases the chance they will be discharged to a nursing home. Such a disease clearly would grab the public's attention, and even in these difficult times, money would be diverted to find a cure. This problem exists today in many of our communities: crowding.
The FDA has approved fesoterodine fumarate for the treatment of overactive bladder.
The continued shortage of the Haemophilus influenza type b (Hib) vaccine has not led to an increase in Haemophilus infections according to the MMWR.